The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ezmekly (mirdametinib) for the treatment of ...
By Annette Bakker The tragedy of rare disease is not only measured in lives lost—it’s also measured in lives that could have ...
TipRanks on MSN
Tyra Bioscience Appoints Bhavesh Ashar as COO
Tyra Bioscience s announced the appointment of Bhavesh Ashar as Chief Operating Officer, effective December 1, 2025, succeeding Daniel Bensen who will become the Chief Discovery O ...
Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision ...
CT Insider on MSN
New Haven-based Halda Therapeutics to be acquired for $3 billion by Johnson & Johnson
Johnson & Johnson's planned $3 billion acquisition of Halda Therapeutics is one of the largest deals for a CT-based biotech company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback